Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Sex hormones, especially androgens, play a key role in causing acne.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

All three treatments reduce hirsutism, but spironolactone works best long-term.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride may help some women with hair loss, but better options exist.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.